Michael Franken
2013
In 2013, Michael Franken earned a total compensation of $1.2M as President, Biosimilars Business and Senior Vice President at Momenta Pharmaceuticals.
Compensation breakdown
| Option Awards | $772,366 |
|---|---|
| Salary | $19,000 |
| Stock Awards | $430,750 |
| Total | $1,222,116 |
Franken received $772.4K in option awards, accounting for 63% of the total pay in 2013.
Franken also received $19K in salary and $430.8K in stock awards.
Rankings
In 2013, Michael Franken's compensation ranked 5,769th out of 12,286 executives tracked by ExecPay. In other words, Franken earned more than 53.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,769 out of 12,286 | 53rd |
Division Manufacturing | 2,007 out of 4,612 | 57th |
Major group Chemicals And Allied Products | 587 out of 1,462 | 60th |
Industry group Drugs | 420 out of 1,156 | 64th |
Industry Biological Products, Except Diagnostic Substances | 62 out of 196 | 68th |
Source: SEC filing on April 22, 2014.
Franken's colleagues
We found five more compensation records of executives who worked with Michael Franken at Momenta Pharmaceuticals in 2013.
2013
Craig Wheeler
Momenta Pharmaceuticals
Chief Executive Officer
2013
James Roach
Momenta Pharmaceuticals
Chief Medical Officer
2013
Ganesh Kaundinya
Momenta Pharmaceuticals
Chief Scientific Officer
2013
Bruce Leicher
Momenta Pharmaceuticals
General Counsel
2013
Richard Shea
Momenta Pharmaceuticals